Drug Profile
Colorectal cancer vaccine - Shanghai Haixin Biotechnology
Alternative Names: APDC - Shanghai Haixin Biotechnology; autologous tumor lysates pulsed human dendritic cells vaccine - Shanghai Haixin BiotechnologyLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Shanghai Haixin Biotechnology
- Developer Second Military Medical University; Shanghai Haixin Biotechnology
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Colorectal cancer
Most Recent Events
- 22 Mar 2019 Discontinued - Phase-II for Colorectal cancer (Combination therapy, Metastatic disease) in China (IV)
- 17 Feb 2005 Phase-II clinical trials in Colorectal cancer (Metastatic disease, Combination therapy) in China (IV)